Antimicrobial and Anti-biofilm Activity of Metal and Metal Oxide Nanoparticles
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antimicrobial Materials and Surfaces".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 9745
Special Issue Editors
Interests: our group has a particular interest in the biotechnological potential of fungi for the obtaining of bioactive compounds and development of metallic nanoparticles, both for applications such as antimicrobial, antitumor or wound healing agents; our expertise is also focused on pre-clinical toxicological assays for pharmaceutical research
Interests: antibiotic production by Actinobacteria; biochemical pathways organization
Special Issue Information
Dear Colleagues,
The microbial infections caused by several pathogens and the emergence of cases of resistance to available antimicrobials are constantly increasing, mainly due to gene transfer and/or mutation. In this aspect, microbial biofilms are an additional problem. Despite continuous efforts, the discovery of new antimicrobial compounds has not been able to keep up with demand. In addition to the development of new compounds, new strategies and technologies are very important to offer new possibilities of treatment for microbial infections and biofilms.
Among the nanotechnological approaches for nanomaterials applications, different metal and metal oxide nanoparticles have been obtained, and studies regarding their application as antimicrobial or anti-biofilm agents have been performed.
In this regard, this Special Issue is focused on manuscripts describing the development of potential metal and metal oxide nanoparticles as antimicrobial and anti-biofilm agents, mainly those obtained by biological processes, including a discussion of the protein corona formation, characterization, and biocompatibility.
Submissions with this approach, including association of these nanostructured materials with others antimicrobial agents, mechanism of action, and toxicity, are welcome and encouraged.
Dr. Ana Olívia De Souza
Dr. Gabriel Padilla
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.